NCT06483048 2026-03-16MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian CancerMayo ClinicPhase 1 Recruiting12 enrolled
NCT03997968 2024-12-24A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid TumorsCyteir Therapeutics, Inc.Phase 1/2 Completed169 enrolled
NCT00867503 2018-07-24Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian CancerUniversity of ArizonaPhase 2 Completed10 enrolled 12 charts